| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 6.55% | 20.11% | -7.01% | 0.00% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 24.91% | 20.24% | 0.00% |
| Negative volatility | 15.90% | 15.17% | 0.00% |
| Sharpe | 0.79 | Neg | - |
| Sortino | 1.24 | Neg | - |
| 2022 | 2023 | 2024 | 2025 | 2026 | |||
| Selectra J. Lamarck Biotech C Cap $ | - | -9.46% | -7.62% | -18.75% | 21.04% | 6.55% | |
| Equity Sector - Biotechnology | - | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |